References automatically added to CGD since 2024-07-19 (possibly not yet curated) |
---|
Reference | Species | Genes Addressed |
---|
Andres MT, et al. (2024) The Antimicrobial Activity of Human Defensins at Physiological Non-Permeabilizing Concentrations Is Caused by the Inhibition of the Plasma Membrane H(+)-ATPases. Int J Mol Sci 25(13) | C. albicans | |PMA1 |TOK1 |
Boukhira S, et al. (2024) The chemical composition and the preservative, antimicrobial, and antioxidant effects of Thymus broussonetii Boiss. essential oil: an in vitro and in silico approach. Front Chem 12:1402310 | C. albicans | |CYP5 |ERG11 |
Conway TP, et al. (2024) Overlapping coactivator function is required for transcriptional activation by the Candida glabrata Pdr1 transcription factor. Genetics | C. glabrata | |CDR1 |PDR1 |SNF2 |
Guinea J, et al. (2024) Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme. Clin Microbiol Infect | C. parapsilosis | |ERG11 |
Ismail SHH, et al. (2024) Decoding host cell interaction- and fluconazole-induced metabolic alterations and drug resistance in Candida auris. Mycologia :1-21 | C. auris | |CDR1 |ERG11 |
Raj K, et al. (2024) Decoding the role of oxidative stress resistance and alternative carbon substrate assimilation in the mature biofilm growth mode of Candida glabrata. BMC Microbiol 24(1):128 | C. glabrata | |COF1 |ERG11 |ERG9 |ICL1 |MLS1 |NTH1 |PCK1 |TEF3 |
Wang H, et al. (2024) Activity of thonningianin A against Candida albicans in vitro and in vivo. Appl Microbiol Biotechnol 108(1):96 | C. albicans | |MCA1 |
Wang L, et al. (2024) A novel quantitative double antigen sandwich ELISA for detecting total antibodies against Candida albicans enolase 1. Eur J Clin Microbiol Infect Dis | C. albicans | |ENO1 |
Amran AI, et al. (2023) Enolase in Meyerozyma guilliermondii strain SO: Sequential and structural insights of MgEno4581 as a putative virulence factor and host-fungal interactions through comprehensive in silico approaches. Microb Pathog 176:106025 | C. albicans | |ENO1 |
Askari F, et al. (2023) Phosphatidylinositol 3-phosphate regulates iron transport via PI3P-binding CgPil1 protein. Cell Rep 42(8):112855 | C. glabrata | |FTR1 |PIL1 |VPS34 |
Feng J, et al. (2023) Corrigendum to <'CaTip41 regulates protein phosphatase 2A activity, CaRad53 deactivation and the recovery of DNA damage-induced filamentation to yeast form in Candida albicans'>. FEMS Yeast Res 23 | C. albicans | |RAD53 |TIP41 |
Liu L, et al. (2023) Novel spiro[pyrrolidine-2,3'-quinoline]-2'-one derivatives containing piperazine fragment as potential chitin synthase inhibitors and antifungal agents: Design, synthesis and biological evaluation. Eur J Med Chem 260:115777 | C. albicans | |CHS2 |
Liu Z, et al. (2023) Biosensor-Enabled Discovery of CaERG6 Inhibitors and Their Antifungal Mode of Action against Candida albicans. ACS Infect Dis 9(4):785-800 | C. albicans | |ERG6 |
Piao J, et al. (2023) Quantitatively detecting Candida albicans enolase1 with a one-step double monoclonal antibody sandwich ELISA assay. Front Microbiol 14:1078709 | C. albicans | |ENO1 |
de Morais MC, et al. (2023) Synthetic Cinnamides and Cinnamates: Antimicrobial Activity, Mechanism of Action, and In Silico Study. Molecules 28(4) | C. albicans | |HOS2 |RPD3 |
Abdoli M, et al. (2022) Benzenesulfonamides Incorporating Hydantoin Moieties Effectively Inhibit Eukaryoticand Human Carbonic Anhydrases. Int J Mol Sci 23(22) | C. glabrata | |NCE103 |
Bachtiar BM, et al. (2022) Validation of RNA Aptamer Probes to Image Candida albicans in Paraffin-Embedded Sections of Wistar Rat Tongue. Eur J Dent 16(3):543-548 | C. albicans | |APT1 |
Bhakt P, et al. (2022) The SET-domain protein CgSet4 negatively regulates antifungal drug resistance via the ergosterol biosynthesis transcriptional regulator CgUpc2a. J Biol Chem 298(10):102485 | C. glabrata | |ERG3 |ERG4 |ERG5 |PDR1 |UPC2A |
Carradori S, et al. (2022) Azole-Based Compounds That Are Active against Candida Biofilm: In Vitro, In Vivo and In Silico Studies. Antibiotics (Basel) 11(10) | C. glabrata | |NCE103 |
Clemente de Moraes D, et al. (2022) Effects of beta-lapachone and beta-nor-lapachone on multidrug efflux transporters and biofilms of Candida glabrata. Bioorg Med Chem 63:116749 | C. glabrata | |CDR1 |PDH1 |
Gao A, et al. (2022) Machine-learning-based virtual screening to repurpose drugs for treatment of Candida albicans infection. Mycoses 65(8):794-805 | C. albicans | |GSC1 |GSL1 |
Khatoon R, et al. (2022) Genomic landscape of the DHA1 family in Candida auris and mapping substrate repertoire of CauMdr1. Appl Microbiol Biotechnol 106(21):7085-7097 | C. auris | |MDR1 |
Mirza A, et al. (2022) Epidemiology and Risk Factors of Candidemia Among Hospitalized Patients in a Turkish Tertiary Care Hospital. Clin Lab 68(1) | C. albicans | |SES1 |
Motta EP, et al. (2022) The Anti-Virulence Effect of Vismia guianensis against Candida albicans and Candida glabrata. Antibiotics (Basel) 11(12) | C. albicans | |CYP5 |ERG11 |
Pata J, et al. (2022) Production and Purification of a GFP-Tagged ABC Transporter CaCdr1p. Methods Mol Biol 2507:175-185 | C. albicans | |CDR1 |
Sharma S, et al. (2022) Spontaneous Suppressors against Debilitating Transmembrane Mutants of CaMdr1 Disclose Novel Interdomain Communication via Signature Motifs of the Major Facilitator Superfamily. J Fungi (Basel) 8(5) | C. albicans | |GYP2 |MDR1 |
Silva AFD, et al. (2022) Anti-Candida albicans Activity of Ononin and Other Secondary Metabolites from Platonia Insignis MART. Metabolites 12(11) | C. albicans | |CYP5 |ERG11 |
Battu A, et al. (2021) An Assay to Determine NAD(P)H: Quinone Oxidoreductase Activity in Cell Extracts from Candida glabrata. Bio Protoc 11(21):e4210 | C. glabrata | |PST2 |RFS1 |
Jakab A, et al. (2021) The Negative Effect of Protein Phosphatase Z1 Deletion on the Oxidative Stress Tolerance of Candida albicans Is Synergistic with Betamethasone Exposure. J Fungi (Basel) 7(7) | C. albicans | |PPZ1 |
Liang G, et al. (2021) Dynamic regulation of membrane integrity to enhance l-malate stress tolerance in Candida glabrata. Biotechnol Bioeng 118(11):4347-4359 | C. glabrata | |YAP3 |YAP3b |